No. 6

SAVI SCOUT in the Annals of Surgical Oncology 

The first peer-reviewed journal article on SAVI SCOUT, titled Pilot Study of a New
Nonradioactive Surgical Guidance Technology for Locating Non-palpable Breast Lesions, has been published online in the Annals of Surgical Oncology.
Some key highlights:  
  • 50 patients in two sites underwent breast localization and surgical guidance with SCOUT.
  • Study resulted in 100% surgical success with removal of the target lesion and reflector in all cases.
  • Excellent re-excision rate of 7%, comparable to rates reported for RSL and IOUS.
Participating surgeons strongly favor SCOUT as it optimizes intraoperative surgical
guidance and simplifies scheduling.  The authors conclude, the “options for the surgical excision of non-palpable breast lesions have been expanded with the SCOUT breast localization and surgical guidance system”
The published article is accessible at:

New Directions in Breast Conserving Surgery

Accurately locating non-palpable breast tumors has long been a challenge for breast surgeons. Oncology Central recently interviewed breast surgical oncologist Pat Whitworth, MD, Director of the Nashville Breast Center. In the article, Dr. Whitworth cites the introduction of the SAVI SCOUT® surgical guidance system as one of the biggest advancements in breast tumor localization. Dr. Whitworth credits SCOUT with improving surgical efficiency as well as the patient experience.
Below are highlights from the interview with Dr. Whitworth. To read the entire transcript, here is the Oncology-Central link: http://www.oncology-central.com/2016/01/13/new-directions-in-breast-conserving-surgery-an-interview-with-pat-whitworth-md-and-frank-vicini-md/
For many years, our best option [for locating non-palpable tumors] was wire localization – literally placing a wire into the patient’s breast prior to surgery. With IOUS [intraoperative ultrasound], you can get much better guidance than just guessing where the wire is and trying to dissect down to it, [but] IOUS guidance is cumbersome: You have to remove your retractor, turn the lights down, stop to get a look, put the ultrasound probe down, put your retractor back in place.
In terms of improving surgical efficiency, one of the biggest advances we’ve seen this year is the introduction of the SAVI SCOUT breast localization and surgical guidance system.
In terms of improving surgical efficiency, one of the biggest advances we’ve seen this year is the introduction of the SAVI SCOUT breast localization and surgical guidance system. With SCOUT, everything is retracted and held in place. I can be ready to make the next cut through the tissue, grab the handpiece and make the cut more precisely in reference to the target.
I find SCOUT to be more precise guidance due to the immediate, real-time feedback on the target location as the dissection proceeds. This adds to my confidence tremendously.  With the reflector in position, you get feedback through the entire duration of the case. I’m less concerned about getting to target tissue and not having to take too much extra normal tissue just to be sure of capturing the target, because I know I can get right down to it, even if it’s in the back of the breast.
The SAVI SCOUT reflector can be put in up to seven days before surgery at the patient’s convenience – it doesn’t have to be on the day of the procedure.  Patients don’t have to walk around with a wire sticking out of the breast; it’s convenient and more comfortable for patients.

Upcoming SCOUT Events

Moving Beyond Wires: 
A Non-Radioactive Solution for Breast Tumor Localization
Join us for a 30 minute educational webinar, Tuesday, March 29, 2016 at 4pm ET, and learn more about the SAVI SCOUT, an FDA-cleared breast localization and surgical guidance system that utilizes non-radioactive electromagnetic wave technology to provide real-time guidance during excisional breast procedures.
Speaker: Mary K. Hayes-Macaluso, MD
-Dr. Mary K. Hayes-Macaluso is a board certified radiologist with expertise in women’s imaging.  She earned her medical degree from New Jersey Medical School and completed her residency at Cedars Sinai Medical Center prior to her fellowship at the UCLA Inris Cantor Center Breast Imaging Center.  She is a member of the ACR Breast Committee on Appropriateness Guidelines and serves as chair of the Guidelines and Standards Breast Imaging Writing Committee.  The Memorial Healthcare centers have been awarded “Centers of Excellence” by the ACR.
SBI/ACR Breast Imaging Symposium
April 7-10, 2016, Austin, Texas
Join us for lunch and learn more about SAVI SCOUT®, 
an FDA-cleared surgical guidance system that utilizes electromagnetic wave technology to provide real-time guidance during lumpectomies.

Speaker: Mary K. Hayes-Macaluso, MD                            Location: Room 310/311
Date: Thursday, April 7, 2016                                             Non-CME Lunch Symposium
Time: 12:30pm-1:30pm                                                       Lunch buffet will be provided&nbnbsp;
Click here to register:  www.regonline.com/SBILUNCH           


Interested in Being a Leader in Your Community?


If you and your institution are committed to adopting new technologies to give women better breast cancer treatment options, please complete this short SCOUT Questionnaire. We promise to continue our efforts to deliver the highest level of customer service, and are proud to be offering this technology to the breast cancer community.

How Does SCOUT Work?
SAVI SCOUT surgical guidance system uses non-radioactive, wave technology similar to radar to provide real-time surgical guidance during breast surgery. The system consists of an electromagnetic wave reflective device (reflector), handpiece and console. The surgeon uses the handpiece to detect the location of the implanted reflector. The console provides real-time audible and visual indicators of the proximity of the reflector, giving surgeons a precise way to target tissue for removal.
SAVI SCOUT Surgical Guidance System



This e-newsletter is brought to you by Cianna  Medical, Inc., a women’s health company dedicated to the innovative treatment of early-stage breast cancer. As the only company dedicated exclusively to breast conservation therapy, Cianna’s commitment is to improve care and reduce the burden breast cancer treatment places on nearly 300,000 women and their loved ones each year.